Skip to content

Effect of Anesthetics on CD39 and CD73 After Open-heart Surgery

Effect of Propofol and Sevoflurane on Serum CD39 and CD73 Level After Open Heart Surgery With Cardiopulmonary Bypass

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02136979
Enrollment
2
Registered
2014-05-13
Start date
2014-05-21
Completion date
2017-08-10
Last updated
2018-01-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aortic Disease, Valvular Heart Disease

Brief summary

CD39 and CD73 was known protein expressed on surface of Th1 and Th17 cell and modulate immune related reaction. Cardiopulmonary bypass (CPB) can induce inflammatory reaction during cardiac surgery, and induce immunosuppression. Propofol and volatile anesthetics were related to immune reaction. However, the effect of propofol and sevoflurane on the change of CD39 and CD73 after CPB was not evaluated in previous studies. The authors hypothesized that the expression of CD39 and CD73 would differ between propofol- and volatile anaesthetic-based anaesthesia in patients undergoing CPB. Therefore, the present study determined the effect of propofol and sevoflurane on CD39 and CD73 during and after CPB.

Detailed description

After obtaining permission of the Institutional Review Board of Konkuk University Medical Center, Seoul, South Korea , patients scheduled to undergo elective cardiac surgery under cardiopulmonary bypass (CPB) after signed written informed consent agreements and prospectively participate in the present study. All patients got a cardiac surgery under moderate hypothermic cardiopulmonary bypass (CPB) by one cardiac surgeon. Also, 6ml of blood and sample was obtained for total 5 times in consecutive order. 1. Before operation (pre-CPB1) 2. 15 minute after successful CPB weaning (post-CPB1) 3. 3 hrs after CPB weaning (post-CPB2) 4. 24 hrs after CPB weaning (post-CPB3) 5. 48 hrs after CPB weaning (post-CPB4) The following intraoperative exclusion criteria are applied: 1. Emergency operation that could not obtain pre-CPB1 sample 2. Patients who have infectious factor before operation 3. Patients who have immunosuppressive agent for underlying disease before operation 4. Patients who have history of cancer previously 5. Patients who are younger than 19 years old Using blood sample, authors examined as follows 1. Flow cytometry for Th 17 and Th 1 cell. 2. Immunocytochemistry for CD39, CD73. 3. Assay for IL 1,6,10,17,IFN-γ, and TNF-α 4. patient vital sign during operation 5. other laboratory tests Statistical analyses are conducted using SPSS 20.0 (SPSS Inc., Chicago, IL, USA). CD39 and CD73 are analysed used a Repeated Measures Analysis of Variance and their pairwise multiple comparisons are performed via the tukey method. The comparisons of the other continuous variables are performed by paired t or Wilcoxon Signed Rank tests. Data are expressed as mean ± SD (95% confidence interval. CI) or median (25%-75%), and number of the patients. A p value less than 0.05 is considered statistically significant.

Interventions

DRUGPropofol

group of patients with propofol-based anesthesia

DRUGSevoflurane

group of patients with sevoflurane-based anesthesia

Sponsors

Konkuk University Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
BASIC_SCIENCE
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
19 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

1. patients scheduled to undergo elective cardiac surgery 2. signed written informed consent agreements

Exclusion criteria

1. Emergency operation that could not obtain pre-CPB1 sample 2. Patients who have infectious factor before operation 3. Patients who have immunosuppressive agent for underlying disease before operation 4. Patients who have history of cancer previously 5. Patients who are younger than 19 years old

Design outcomes

Primary

MeasureTime frameDescription
The level of CD39 and CD73 between propofol and sevoflurane group after CPBfrom preoperative status up to 48 hrs after CPB weaning statusThe difference of CD39 and CD73 level between propofol and sevoflurane group

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026